7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardiac Precision Medicine
Precision medicine in cardiology is a groundbreaking approach that revolutionizes the way we understand and treat cardiovascular diseases. By meticulously analyzing an individual's unique genetic, molecular, and clinical attributes, precision medicine aims to develop highly personalized strategies for managing heart conditions. This transformative field leverages state-of-the-art technologies like advanced imaging, molecular profiling, and artificial intelligence to decipher the intricate details of a patient's cardiovascular health. Through this approach, clinicians can identify specific genetic markers and molecular signatures, allowing for more precise diagnoses and tailored therapeutic interventions. Precision medicine in cardiology holds the promise of delivering targeted and optimized care, ushering in a new era of cardiovascular health management.
Arthur J Siegel
Massachusetts General Hospital, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Arthur J Siegel
Massachusetts General Hospital, United States
Yong Xiao Wang
Albany Medical Center, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian FederationSubmit your abstract Today
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with Major Adverse Cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical School, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt
Title : Successful treatment of sinus of valsalva aneurysm
Aina Jarillo, Universidad Anahuac Mexico Norte, Mexico
Title : Metabolic and echocardiographic predictors of ventricular extrasystoles burden in non-ischemic patients
Ahmed Ahmed Mohamed Hassan, Al-Azhar Medical School, Egypt